NAC	Neoadjuvant chemotherapy
TNBC	Triple-negative breast cancer
ER	Estrogen receptor
PR	Progesterone receptor
HER-2	Human epidermal growth factor receptor-2
ICI	Immune checkpoint inhibitor
PD-l	Programmed cell death protein 1
PD-L1	Programmed cell death ligand 1
NACI	Neoadjuvant chemoimmunotherapy
pCR	Pathologic complete response
MRI	Magnetic resonance imaging
DCE-MRI	Dynamic contrast-enhanced MRI
DWI	Diffusion-weighted imaging
ADC	Apparent diffusion coefficient
rCR	Radiologic complete response
UF-MRI	Ultrafast MRI
FTV	Functional tumor volume
HEV	High enhancement volume
TME	Tumor microenvironment
T-VEC	Talimogene laherparepvec